Your browser doesn't support javascript.
loading
Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors.
Replogle, Joseph M; Bonnar, Jessica L; Pogson, Angela N; Liem, Christina R; Maier, Nolan K; Ding, Yufang; Russell, Baylee J; Wang, Xingren; Leng, Kun; Guna, Alina; Norman, Thomas M; Pak, Ryan A; Ramos, Daniel M; Ward, Michael E; Gilbert, Luke A; Kampmann, Martin; Weissman, Jonathan S; Jost, Marco.
Afiliação
  • Replogle JM; Medical Scientist Training Program, University of California, San Francisco, San Francisco, United States.
  • Bonnar JL; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.
  • Pogson AN; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.
  • Liem CR; Whitehead Institute for Biomedical Research, Cambridge, United States.
  • Maier NK; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.
  • Ding Y; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.
  • Russell BJ; Whitehead Institute for Biomedical Research, Cambridge, United States.
  • Wang X; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.
  • Leng K; Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States.
  • Guna A; Whitehead Institute for Biomedical Research, Cambridge, United States.
  • Norman TM; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.
  • Pak RA; Department of Microbiology, Harvard Medical School, Boston, United States.
  • Ramos DM; Department of Microbiology, Harvard Medical School, Boston, United States.
  • Ward ME; Department of Microbiology, Harvard Medical School, Boston, United States.
  • Gilbert LA; Department of Microbiology, Harvard Medical School, Boston, United States.
  • Kampmann M; Medical Scientist Training Program, University of California, San Francisco, San Francisco, United States.
  • Weissman JS; Institute for Neurodegenerative Disease, University of California, San Francisco, San Francisco, United States.
  • Jost M; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, United States.
Elife ; 112022 12 28.
Article em En | MEDLINE | ID: mdl-36576240
ABSTRACT
CRISPR interference (CRISPRi) enables programmable, reversible, and titratable repression of gene expression (knockdown) in mammalian cells. Initial CRISPRi-mediated genetic screens have showcased the potential to address basic questions in cell biology, genetics, and biotechnology, but wider deployment of CRISPRi screening has been constrained by the large size of single guide RNA (sgRNA) libraries and challenges in generating cell models with consistent CRISPRi-mediated knockdown. Here, we present next-generation CRISPRi sgRNA libraries and effector expression constructs that enable strong and consistent knockdown across mammalian cell models. First, we combine empirical sgRNA selection with a dual-sgRNA library design to generate an ultra-compact (1-3 elements per gene), highly active CRISPRi sgRNA library. Next, we compare CRISPRi effectors to show that the recently published Zim3-dCas9 provides an excellent balance between strong on-target knockdown and minimal non-specific effects on cell growth or the transcriptome. Finally, we engineer a suite of cell lines with stable expression of Zim3-dCas9 and robust on-target knockdown. Our results and publicly available reagents establish best practices for CRISPRi genetic screening.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas / RNA Guia de Sistemas CRISPR-Cas Tipo de estudo: Guideline Idioma: En Revista: Elife Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Repetições Palindrômicas Curtas Agrupadas e Regularmente Espaçadas / RNA Guia de Sistemas CRISPR-Cas Tipo de estudo: Guideline Idioma: En Revista: Elife Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos